Cargando…
Utilization of Anticoagulants in Nonvalvular Atrial Fibrillation Before and After Catheter Ablation at Shanghai, China
Both vitamin K antagonists (VKAs) and novel oral anticoagulants (NOACs) are effective for stroke prevention in nonvalvular atrial fibrillation (NVAF) patients. This study evaluated the utilization of VKA and NOACs in NVAF patients before and after catheter ablation in China. Prescription data were r...
Autores principales: | Tingting, Chen, Yuzhu, Wang, Lin, Zhang, Ran, Li, Jing, Li, Yi, Wu, Xiaoyu, Li, Qianzhou, Lv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714957/ https://www.ncbi.nlm.nih.gov/pubmed/30754983 http://dx.doi.org/10.1177/1076029619826260 |
Ejemplares similares
-
Physician's Fear of Anticoagulant Therapy in Nonvalvular Atrial Fibrillation
por: Sen, Souvik, et al.
Publicado: (2014) -
Evaluation of Remote Pharmacist-Led Outpatient Service for Geriatric Patients on Rivaroxaban for Nonvalvular Atrial Fibrillation During the COVID-19 Pandemic
por: Li, Xiaoye, et al.
Publicado: (2020) -
Body Mass Index Influence on the Clinical Outcomes for Nonvalvular Atrial Fibrillation Patients Admitted to a Hospital Treated with Direct Oral Anticoagulants: A Retrospective Cohort Study
por: Li, Xiaoye, et al.
Publicado: (2021) -
Risk factors for late recurrence in patients with nonvalvular atrial fibrillation after radiofrequency catheter ablation
por: Peng, Zhang, et al.
Publicado: (2021) -
Cardiovascular events and death after catheter ablation in very old patients with nonvalvular atrial fibrillation
por: Okawa, Keisuke, et al.
Publicado: (2023)